Your browser doesn't support javascript.
loading
Necesidad de efectuar análisis de coste/ efectividad para racionalizar y optimizar el gasto en nuevos medicamentos / Needs of cost-effectivity analysis for the optimization and rationalization of expense in new drugs
Soto Álvarez, Javier.
Affiliation
  • Soto Álvarez, Javier; Pfizer. Madrid. España
Med. clín (Ed. impr.) ; 130(14): 559-559, abr. 2008.
Article in Es | IBECS | ID: ibc-64954
Responsible library: ES15.1
Localization: ES15.1 - BNCS
ABSTRACT
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas Health problem: Goal 4: Health financing Database: IBECS Main subject: Cost Efficiency Analysis / Investigational New Drug Application Type of study: Health economic evaluation Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2008 Document type: Article Institution/Affiliation country: Pfizer/España
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas Health problem: Goal 4: Health financing Database: IBECS Main subject: Cost Efficiency Analysis / Investigational New Drug Application Type of study: Health economic evaluation Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2008 Document type: Article Institution/Affiliation country: Pfizer/España